Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) EBIT: 2009-2025

Historic EBIT for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $102.3 million.

  • BIO-TECHNE's EBIT rose 19.18% to $47.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.9 million, marking a year-over-year decrease of 42.39%. This contributed to the annual value of $102.3 million for FY2025, which is 50.53% down from last year.
  • As of FY2025, BIO-TECHNE's EBIT stood at $102.3 million, which was down 50.53% from $206.7 million recorded in FY2024.
  • BIO-TECHNE's EBIT's 5-year high stood at $298.9 million during FY2023, with a 5-year trough of $102.3 million in FY2025.
  • Its 3-year average for EBIT is $202.6 million, with a median of $206.7 million in 2024.
  • As far as peak fluctuations go, BIO-TECHNE's EBIT soared by 50.74% in 2021, and later slumped by 50.53% in 2025.
  • Yearly analysis of 5 years shows BIO-TECHNE's EBIT stood at $237.3 million in 2021, then grew by 24.99% to $296.6 million in 2022, then rose by 0.79% to $298.9 million in 2023, then crashed by 30.86% to $206.7 million in 2024, then plummeted by 50.53% to $102.3 million in 2025.